Search for: "PFIZER" Results 1321 - 1340 of 4,632
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Dec 2016, 2:17 pm by Paul Lyons
The largest single healthcare fraud case this year—in which Wyeth and Pfizer Inc. paid $784.6 million for illegally pricing drugs for Medicaid—was initiated by two whistleblowers. [read post]
14 Dec 2016, 7:39 pm by A. Brian Albritton
 Recoveries from health care qui tams account for $2.427 billion or 93% of the $2.597 billion in health care settlements/recoveries.Relators were awarded $450 million in relator share awards in healthcare cases, up roughly 14% from the year before.As outlined in DOJ's press release, a large portion of the overall healthcare related settlements came from a handful of big settlements: $784.6 million paid by Wyeth and Pfizer; $390 millon paid by Novartis; $244.2 million paid by… [read post]
14 Dec 2016, 7:39 pm by A. Brian Albritton
 Recoveries from health care qui tams account for $2.427 billion or 93% of the $2.597 billion in health care settlements/recoveries.Relators were awarded $450 million in relator share awards in healthcare cases, up roughly 14% from the year before.As outlined in DOJ's press release, a large portion of the overall healthcare related settlements came from a handful of big settlements: $784.6 million paid by Wyeth and Pfizer; $390 millon paid by Novartis; $244.2 million paid by… [read post]
8 Dec 2016, 2:48 pm by Ben Vernia
 The government alleged Wyeth (before it was acquired by Pfizer) violated its Medicaid agreements with the government by failing to report deep discounts it made available to hospitals. [read post]
8 Dec 2016, 8:38 am by Keith Mallinson
I would like to introduce you to guest blogger Trevor Soames, a leading Brussels based antitrust lawyerwith extensive experience of major high tech and IP-related investigations and litigation, having represented several major corporations in various cases over the years including Qualcomm, Nokia, Samsung and Microsoft.The Competition Directorate of the European Commission (DG Comp) has, over the years, become increasingly interested and active in the field of SEPs. [read post]
8 Dec 2016, 3:20 am by Brian Cordery
Kalden, Brinkman and Van Nispen10) How many defendants were there to the Danish action brought by Warner-Lambert and Pfizer in relation to Krka’s generic pregabalin in 2015? [read post]
7 Dec 2016, 7:40 am by Glyn Moody
Enlarge (credit: Franck Fife/AFP/Getty Images) US pharma giant Pfizer and a partnering distributor have been slapped with a record fine for hiking UK drug prices by 2,600% overnight. [read post]
3 Dec 2016, 10:02 am
| BREAKING NEWS Brexit - High Court rules Government cannot Invoke Article 50 under Crown Prerogative | Canada's new approach to diagnostic practices prompts division at CIPONever Too Late 120 [week ending on Sunday 30 October] | Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again | Procedural fairness and the Penalties Regulation: R(Roche) v Secretary of State for Health | Meet the Trade Mark Judges (Part two) | AG Szpunar says that the… [read post]
30 Nov 2016, 11:32 am by David C. Scileppi
He has devoted his career to governance in his prior positions with companies such as Pfizer; CA, Inc.; and W.R. [read post]
30 Nov 2016, 2:42 am
| BREAKING NEWS Brexit - High Court rules Government cannot Invoke Article 50 under Crown Prerogative | Canada's new approach to diagnostic practices prompts division at CIPONever Too Late 120 [week ending on Sunday 30 October] | Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again | Procedural fairness and the Penalties Regulation: R(Roche) v Secretary of State for Health | Meet the Trade Mark Judges (Part two) | AG Szpunar says that the notion… [read post]
29 Nov 2016, 2:30 am
  Commissioner Muscolo gave the Italian Pfizer/Ratiopharm case (where SPCs were obtained and sought to be enforced on the basis of a divisional of the key patent) as an example of this (link to Commissioner Muscolo’s handout distributed at the session hereand original Italian Antitrust Authority decision here, for any Italian speaking kats).The tension between the perceptions of competition authorities and originators was put in sharp relief from a comment from the crowd by Bryan… [read post]
18 Nov 2016, 12:44 am by John Collins
In this case, Pfizer’s expert evidence supported the view that all pain conditions “involve some element of central sensitisation“, even if it is so slight as to be of no clinical relevance in some instances. [read post]
16 Nov 2016, 1:33 pm
| BREAKING NEWS Brexit - High Court rules Government cannot Invoke Article 50 under Crown Prerogative | Canada's new approach to diagnostic practices prompts division at CIPONever Too Late 120 [week ending on Sunday 30 October] | Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again | Procedural fairness and the Penalties Regulation: R(Roche) v Secretary of State for Health | Meet the Trade Mark Judges (Part two) | AG Szpunar says that the notion… [read post]
9 Nov 2016, 9:37 am
This suggests that there simply may be less innovative activity taking place at the startup level.BREAKING NEWS Brexit - High Court rules Government cannot Invoke Article 50 under Crown PrerogativeThe decision of the “Brexit challenge” unanimously found in favour of the claimants who argued that the Government could not invoke Article 50 of the Treaty on European Union (which starts the procedure by which the UK would leave the EU) under so-called "Crown prerogative"… [read post]
3 Nov 2016, 7:00 am by Troy Ungerman
With the Allergan and Pfizer US$160bn deal, the Honeywell and United Technologies US$102bn deal and the Haliburton and Baker Hughes US$38bn deal all failing to close in the first half of 2016, this year was on track to be building upon 2015’s success instead of failing to meet expectations. [read post]
2 Nov 2016, 9:30 pm by Alex Walsh
Months after the announcement of the proposed Pfizer-Allergan deal, the U.S. [read post]
2 Nov 2016, 3:44 pm
Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted againDarren Smyth blogged on the painful decision handed down by the Court of Appeal in the pregabalin appeal. [read post]